No Data
No Data
Citi Says 'Buy' These Stocks in '25; SA Quant Ratings Says Maybe Not
Bernstein Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $70
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Denali Therapeutics (DNLI) and Inspire Medical Systems (INSP)
Evercore Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $70
Exact Sciences Price Target Raised to $70 From $60 at Evercore ISI
Exact Sciences to Participate in J.P. Morgan Healthcare Conference
Unlock the Full List
Alen Kok : Oh